-
1
-
-
0842332512
-
High-throughput screening for stability and inhibitory activity of compounds toward cytochrome P450-mediated metabolism
-
Ansede JH, Thakker DR (2004). High-throughput screening for stability and inhibitory activity of compounds toward cytochrome P450-mediated metabolism. J Pharm Sci. 93:239-255.
-
(2004)
J Pharm Sci
, vol.93
, pp. 239-255
-
-
Ansede, J.H.1
Thakker, D.R.2
-
2
-
-
31344449488
-
Luminescent assays for recombinant and liver microsome cytochrome P450 activities
-
Call JJ, Ho S, Ma D, Simpson D (2003). Luminescent assays for recombinant and liver microsome cytochrome P450 activities. Drug Metab Rev. 35:28.
-
(2003)
Drug Metab Rev
, vol.35
, pp. 28
-
-
Call, J.J.1
Ho, S.2
Ma, D.3
Simpson, D.4
-
3
-
-
3042658599
-
In vivo inhibition of Abeta production by memapsin 2 (betasecretase) inhibitors
-
Chang WP, Koelsch G, Wong S, Downs D, Da H, Weerasena V, Gordon B, Devasamudram T, Bilcer G, Ghosh AK, Tang J (2004). In vivo inhibition of Abeta production by memapsin 2 (betasecretase) inhibitors. J Neurochem. 89:1409-1416.
-
(2004)
J Neurochem
, vol.89
, pp. 1409-1416
-
-
Chang, W.P.1
Koelsch, G.2
Wong, S.3
Downs, D.4
Da, H.5
Weerasena, V.6
Gordon, B.7
Devasamudram, T.8
Bilcer, G.9
Ghosh, A.K.10
Tang, J.11
-
4
-
-
0029619210
-
Photonic detection of bacterial pathogens in living hosts
-
Contag CH, Contag PR, Mullins JI, Spilman SD, Stevenson DK, Benaron DA (1995). Photonic detection of bacterial pathogens in living hosts. Mol Microbiol. 18:593-603.
-
(1995)
Mol Microbiol
, vol.18
, pp. 593-603
-
-
Contag, C.H.1
Contag, P.R.2
Mullins, J.I.3
Spilman, S.D.4
Stevenson, D.K.5
Benaron, D.A.6
-
5
-
-
4544232468
-
Inhibitors of dipeptidyl peptidase IV: A novel approach for the prevention and treatment of Type 2 diabetes?
-
Deacon CF, Ahren B, Hoist JJ (2004). Inhibitors of dipeptidyl peptidase IV: A novel approach for the prevention and treatment of Type 2 diabetes? Expert Opin Investig Drugs. 13:1091-1102.
-
(2004)
Expert Opin Investig Drugs
, vol.13
, pp. 1091-1102
-
-
Deacon, C.F.1
Ahren, B.2
Hoist, J.J.3
-
6
-
-
0344097277
-
Induction of cytochrome P-450 enzymes after repeated exposure to 4-vinylcyclohexene in B6C3F1 mice
-
Doerr-Stevens JK, Liu J, Stevens GJ, Kraner JC, Fontaine SM, Halpert JR, Sipes IG (1999). Induction of cytochrome P-450 enzymes after repeated exposure to 4-vinylcyclohexene in B6C3F1 mice. Drug Metab Dispos. 27:281-287.
-
(1999)
Drug Metab Dispos
, vol.27
, pp. 281-287
-
-
Doerr-Stevens, J.K.1
Liu, J.2
Stevens, G.J.3
Kraner, J.C.4
Fontaine, S.M.5
Halpert, J.R.6
Sipes, I.G.7
-
7
-
-
2042474777
-
Effect of cytochrome P450 3A4 inhibition on the pharmacokinetics of docetaxel
-
Engels FK, Ten Tije AJ, Baker SD, Lee CK, Loos WJ, Vulto AG, Verweij J, Sparreboom A (2004). Effect of cytochrome P450 3A4 inhibition on the pharmacokinetics of docetaxel. Clin Pharmacol Ther. 75:448-454.
-
(2004)
Clin Pharmacol Ther
, vol.75
, pp. 448-454
-
-
Engels, F.K.1
Ten Tije, A.J.2
Baker, S.D.3
Lee, C.K.4
Loos, W.J.5
Vulto, A.G.6
Verweij, J.7
Sparreboom, A.8
-
8
-
-
2542447230
-
Techniques: Reporter mice - A new way to look at drug action
-
Maggi A, Ottobrini L, Biserni A, Lucignani G, Ciana P (2004). Techniques: Reporter mice - a new way to look at drug action. Trends Pharmacol Sci. 25:337-342.
-
(2004)
Trends Pharmacol Sci
, vol.25
, pp. 337-342
-
-
Maggi, A.1
Ottobrini, L.2
Biserni, A.3
Lucignani, G.4
Ciana, P.5
-
9
-
-
0023897416
-
A new type of ultrasensitive bioluminogenic enzyme substrates: I. Enzyme substrates with D-luciferin as leaving group
-
Miska W, Geiger R (1988). A new type of ultrasensitive bioluminogenic enzyme substrates: I. Enzyme substrates with D-luciferin as leaving group. Biol Chem Hoppe Seyler. 369: 407-411.
-
(1988)
Biol Chem Hoppe Seyler
, vol.369
, pp. 407-411
-
-
Miska, W.1
Geiger, R.2
-
11
-
-
23244464739
-
Thymidylate synthase: A critical target in cancer therapy?
-
Rustum YM (2004). Thymidylate synthase: A critical target in cancer therapy? Front Biosci. 9:2467-2473.
-
(2004)
Front Biosci
, vol.9
, pp. 2467-2473
-
-
Rustum, Y.M.1
-
12
-
-
0031569864
-
Mouse cytochrome P450 (Cyp3a11): Predominant expression in liver and capacity to activate aflatoxin B1
-
Yanagimoto T, Itoh S, Sawada M, Kamataki T (1997). Mouse cytochrome P450 (Cyp3a11): Predominant expression in liver and capacity to activate aflatoxin B1. Arch Biochem Biopbys. 340:215-218.
-
(1997)
Arch Biochem Biopbys
, vol.340
, pp. 215-218
-
-
Yanagimoto, T.1
Itoh, S.2
Sawada, M.3
Kamataki, T.4
-
13
-
-
8444237774
-
A Cyp la2-luciferase transgenic CD-1 mouse model: Responses to aryl hydrocarbons similar to the humanized AhR mice
-
Zhang W, Moorthy B, Chen M, Muthiah K, Coffee R, Purchio AF, West DB (2004). A Cyp la2-luciferase transgenic CD-1 mouse model: Responses to aryl hydrocarbons similar to the humanized AhR mice. Toxicol Sci. 82:297-307.
-
(2004)
Toxicol Sci
, vol.82
, pp. 297-307
-
-
Zhang, W.1
Moorthy, B.2
Chen, M.3
Muthiah, K.4
Coffee, R.5
Purchio, A.F.6
West, D.B.7
|